Evidence map›Paper›PMID 16331262›Full record

ArticleOncogene2006

TA-p63-gamma regulates expression of DeltaN-p63 in a manner that is sensitive to p53.

N Li, H Li, P Cherukuri, S Farzan, D C Harmes, J DiRenzo

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. The role of p63 in cancer, stem cells and cancer stem cells.Cellular & molecular biology letters · 2011
    Review
  7. Article
  8. Article
  9. Article
  10. TAp63 is a transcriptional target of NF-kappaB.Journal of cellular biochemistry · 2010
    Article
  11. Article
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

N LiDepartment of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, NH 03755, USA.
H Li
P Cherukuri
S Farzan
D C Harmes
J DiRenzo
Dartmouth College · US

Funding

Role of DN-p63 in Preservation of Self RenewalR01CA108539 · NCI · DARTMOUTH COLLEGE · PI DIRENZO, JAMES · 2005 to 2009
$1.4M
NCI NIH HHS 1R01 CA108539
6 · The paper itself

Abstract

Genetic analysis indicates that TP63 is required for establishment and preservation of self-renewing progenitors within the basal layer of several epithelial structures, however, the specific contributions of transactivating (TA-p63) and dominant-negative (DeltaN-p63) isoforms remain largely undefined. Recent studies have suggested a model in which TA-p63 plays an important role in the establishment of progenitor populations in which expression of DeltaN-p63 contributes to the preservation of self-renewing capacity. Our previous studies indicate that DeltaN-p63 is a transcriptional target of p53, however, the absence of overt epithelial deficiencies in p53-/- mice and reports of increased expression of DeltaN-p63 in p53-/- mice suggest p53-independent mechanisms also contribute to expression of DeltaN-p63. Here, we present data indicating that, prolonged loss of p53 leads to the activation of a p53-independent mechanism for transcriptional regulation of DeltaN-p63. This p53-independent mechanism is sensitive to ectopic p53 but not to a p53 mutant that lacks the transactivation domain. We further show that in cells in which p53 is expressed TA-p63-gamma protein is destabilized in a manner that is p53 dependent and sensitive to pharmacologic inhibition of the 26S proteosome. Consistent with this observation, we demonstrate that loss of p53 leads to the stabilization of TA-p63-gamma that is reversible by ectopic p53. Finally, we present evidence that disruption of TA-p63-gamma expression leads to decreased expression of DeltaN-p63 and that overexpression of TA-p63-gamma was sufficient to enhance the activity of the DeltaN-p63 promoter. Taken together, our studies indicate that TA-p63-gamma is capable of activating expression of DeltaN-p63 and that this mechanism may account for p53-independent expression of DeltaN-p63.

Indexed as

BreastCycloheximideDNA-Binding ProteinsEpithelial CellsFemaleGenes, Tumor SuppressorHumansPhosphoproteinsProtein IsoformsRNA, MessengerStem CellsTrans-ActivatorsTranscription FactorsTumor Suppressor Protein p53Tumor Suppressor ProteinsCycloheximideDNA-Binding ProteinsPhosphoproteinsProtein IsoformsRNA, MessengerTP63 protein, humanTrans-ActivatorsTranscription FactorsTumor Suppressor Protein p53Tumor Suppressor Proteins

Identifiers

PMID16331262
OpenAlexW1501825044

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.